NEW YORK (GenomeWeb News) – The proteomics company Cellworks Group will work with ISP Personal Care, a developer of chemicals for use in personal and other products, to come up with novel proteomics-based skin care approaches using ISP's chemicals, the companies said today.
Cellworks Group already has used its Virtual Skin platform to assay hundreds of bio-molecules and allowing ISP to predict their effects on different skin types, before the bio-molecules advance to the clinical trial phase.
The Virtual Skin technology models the interactions of multiple cell types in order to give researchers knowledge about the interaction of a compound with human cells.
That collaboration was the first in a series between the companies that will include studies on anti-aging compounds and of different bio-functional ingredients.